Inflammatory markers in a 2-year soy intervention among premenopausal women

Gertraud Maskarinec, Jana S Steude, Adrian A Franke, Robert V Cooney, Gertraud Maskarinec, Jana S Steude, Adrian A Franke, Robert V Cooney

Abstract

Background: Epidemiologic evidence supports a role of soy foods in breast cancer etiology. Because chronic inflammation appears to be a critical component in carcinogenesis, we examined the potential anti-inflammatory effects of soy foods.

Methods: The original 2-year dietary intervention randomized 220 premenopausal women of whom 183 women (90 in the intervention group and 93 in the control group) were included in the current investigation; 40% were of Asian ancestry. The intervention group consumed two daily soy servings containing 50 mg of isoflavones (aglycone equivalents), whereas the controls maintained their regular diet. Five serum samples obtained at month 0, 3, 6, 12, and 24 were analyzed for interleukin (IL)-6, C-reactive protein (CRP), leptin, and adiponectin by ELISA. For statistical analysis, mixed models were applied to incorporate the repeated measurements.

Results: The levels of all analytes were lower in Asian than Caucasian women. Overweight women had significantly higher levels of CRP, IL-6, and leptin and lower levels of adiponectin than normal weight women. We did not observe a significant effect of soy foods on the four markers, but leptin increased in the control and not in the intervention group (p = 0.20 for group-time effect); this difference was significant for Asian (p = 0.01) and obese women (p = 0.005).

Conclusion: During this 2-year intervention, soy foods did not modify serum levels of CRP, IL-6, leptin, and adiponectin in premenopausal women although leptin levels remained stable among women in the intervention group who were obese or of Asian ancestry. Further studies with diverse markers of inflammation are necessary to clarify the specific effect of soy on immune responses.

References

    1. Messina M, Barnes S. The role of soy products in reducing risk of cancer. J Natl Cancer Inst. 1991;83:541–546. doi: 10.1093/jnci/83.8.541.
    1. Adlercreutz H. Phyto-oestrogens and cancer. Lancet Oncol. 2002;3:364–373. doi: 10.1016/S1470-2045(02)00777-5.
    1. Trock BJ, Hilakivi-Clarke L, Clarke R. Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst. 2006;98:459–471.
    1. Wu AH, Yu MC, Tseng CC, Pike MC. Epidemiology of soy exposures and breast cancer risk. Br J Cancer. 2008;98:9–14. doi: 10.1038/sj.bjc.6604145.
    1. Barnes S. Soy isoflavones – phytoestrogens and what else? J Nutr. 2004;134:1225S–1228S.
    1. Maskarinec G, Franke AA, Williams AE, Hebshi S, Oshiro C, Murphy SP, Stanczyk FZ. Effects of a 2-year randomized soy intervention on sex hormone levels in premenopausal women. Cancer Epidemiol Biomarkers Prev. 2004;13:1736–1744.
    1. Duncan AM, Merz BE, Xu X, Nagel TC, Phipps WR, Kurzer MS. Soy isoflavones exert modest hormonal effects in premenopausal women. J Clin Endocrinol Metab. 1999;84:192–197. doi: 10.1210/jc.84.1.192.
    1. Kumar NB, Cantor A, Allen K, Riccardi D, Cox CE. The specific role of isoflavones on estrogen metabolism in premenopausal women. Cancer. 2002;94:1166–1174. doi: 10.1002/cncr.10320.
    1. Wu AH, Stanczyk FZ, Martinez C, Tseng CC, Hendrich S, Murphy P, Chaikittisilpa S, Stram DO, Pike MC. A controlled 2-mo dietary fat reduction and soy food supplementation study in postmenopausal women. Am J Clin Nutr. 2005;81:1133–1141.
    1. Verheus M, Peeters PH, Van Noord PA, Schouw YT van der, Grobbee DE, van Gils CH. No relationship between circulating levels of sex steroids and mammographic breast density: the Prospect-EPIC cohort. Breast Cancer Res. 2007;9:R53. doi: 10.1186/bcr1758.
    1. Il'yasova D, Colbert LH, Harris TB, Newman AB, Bauer DC, Satterfield S, Kritchevsky SB. Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort. Cancer Epidemiol Biomarkers Prev. 2005;14:2413–2418. doi: 10.1158/1055-9965.EPI-05-0316.
    1. Lorincz AM, Sukumar S. Molecular links between obesity and breast cancer. Endocr Relat Cancer. 2006;13:279–292. doi: 10.1677/erc.1.00729.
    1. Ryan-Borchers TA, Park JS, Chew BP, McGuire MK, Fournier LR, Beerman KA. Soy isoflavones modulate immune function in healthy postmenopausal women. Am J Clin Nutr. 2006;83:1118–1125.
    1. Gottstein N, Ewins BA, Eccleston C, Hubbard GP, Kavanagh IC, Minihane AM, Weinberg PD, Rimbach G. Effect of genistein and daidzein on platelet aggregation and monocyte and endothelial function. Br J Nutr. 2003;89:607–616. doi: 10.1079/BJN2003820.
    1. Blum A, Lang N, Peleg A, Vigder F, Israeli P, Gumanovsky M, Lupovitz S, Elgazi A, Ben Ami M. Effects of oral soy protein on markers of inflammation in postmenopausal women with mild hypercholesterolemia. Am Heart J. 2003;145:e7. doi: 10.1067/mhj.2003.115.
    1. Verdrengh M, Jonsson IM, Holmdahl R, Tarkowski A. Genistein as an anti-inflammatory agent. Inflamm Res. 2003;52:341–346. doi: 10.1007/s00011-003-1182-8.
    1. Kim YK, Jang YY, Kim DH, Ko HH, Han ES, Lee CS. Differential regulation of protein tyrosine kinase on free radical production, granule enzyme release, and cytokine synthesis by activated murine peritoneal macrophages. Biochem Pharmacol. 2001;61:87–96. doi: 10.1016/S0006-2952(00)00531-1.
    1. Maskarinec G, Takata Y, Franke AA, Williams AE, Murphy SP. A 2-year soy intervention in premenopausal women does not change mammographic densities. J Nutr. 2004;134:3089–3094.
    1. Wong E, Freiberg M, Tracy R, Kuller L. Epidemiology of cytokines: the Women On the Move through Activity and Nutrition (WOMAN) Study. Am J Epidemiol. 2008;168:443–453. doi: 10.1093/aje/kwn132.
    1. Marti A, Marcos A, Martinez JA. Obesity and immune function relationships. Obes Rev. 2001;2:131–140. doi: 10.1046/j.1467-789x.2001.00025.x.
    1. Garofalo C, Surmacz E. Leptin and cancer. J Cell Physiol. 2006;207:12–22. doi: 10.1002/jcp.20472.
    1. Tilg H, Wolf AM. Adiponectin: a key fat-derived molecule regulating inflammation. Expert Opin Ther Targets. 2005;9:245–251. doi: 10.1517/14728222.9.2.245.
    1. Franke AA, Hankin JH, Yu MC, Maskarinec G, Low SH, Custer LJ. Isoflavone levels in soy foods consumed by multiethnic populations in Singapore and Hawaii. J Agric Food Chem. 1999;47:977–986. doi: 10.1021/jf9808832.
    1. Franke AA, Custer LJ, Wang W, Shi SJ. HPLC analysis of isoflavonoids and other phenolic agents from foods and from human fluids. Proc Soc Exp Biol Med. 1998;217:263–273.
    1. Maskarinec G, Robbins C, Riola B, Kane-Sample L, Franke A, Murphy S. Three measures show high compliance in soy intervention among premenopausal women. J Am Diet Assoc. 2003;103:861–866. doi: 10.1016/S0002-8223(03)00377-8.
    1. Littell RC, Milliken GA, Stroup WW, Wolfinger RD. SAS system for mixed models. Cary, NC: SAS Institute Inc; 1996.
    1. SAS Institute Inc . SAS OnlineDoc 912. Cary, NC: SAS Institute Inc; 2004.
    1. Singer JD, Willett JB. Applied longitudinal data analysis: Modeling change and event occurrence. Oxford: Oxford University Press; 2003.
    1. Jenkins DJ, Kendall CW, Jackson CJ, Connelly PW, Parker T, Faulkner D, Vidgen E, Cunnane SC, Leiter LA, Josse RG. Effects of high- and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women. Am J Clin Nutr. 2002;76:365–372.
    1. Nikander E, Metsa-Heikkila M, Tiitinen A, Ylikorkala O. Evidence of a lack of effect of a phytoestrogen regimen on the levels of C-reactive protein, E-selectin, and nitrate in postmenopausal women. J Clin Endocrinol Metab. 2003;88:5180–5185. doi: 10.1210/jc.2003-030362.
    1. D'Anna R, Baviera G, Corrado F, Cancellieri F, Crisafulli A, Squadrito F. The effect of the phytoestrogen genistein and hormone replacement therapy on homocysteine and C-reactive protein level in postmenopausal women. Acta Obstet Gynecol Scand. 2005;84:474–477. doi: 10.1111/j.0001-6349.2005.00661.x.
    1. Greany KA, Nettleton JA, Wangen KE, Thomas W, Kurzer MS. Consumption of isoflavone-rich soy protein does not alter homocysteine or markers of inflammation in postmenopausal women. Eur J Clin Nutr. 2007;62:1419–1425. doi: 10.1038/sj.ejcn.1602885.
    1. Tormala R, Appt S, Clarkson TB, Mueck AO, Seeger H, Mikkola TS, Ylikorkala O. Impact of soy supplementation on sex steroids and vascular inflammation markers in postmenopausal women using tibolone: role of equol production capability. Climacteric. 2008;11:409–415. doi: 10.1080/13697130802251344.
    1. Maskarinec G, Oum R, Chaptman AK, Ognjanovic S. Inflammatory markers in a randomised soya intervention among men. Br J Nutr. 2008:1–5. doi: 10.1017/S0007114508147389.
    1. Yildiz MF, Kumru S, Godekmerdan A, Kutlu S. Effects of raloxifene, hormone therapy, and soy isoflavone on serum high-sensitive C-reactive protein in postmenopausal women. Int J Gynaecol Obstet. 2005;90:128–133. doi: 10.1016/j.ijgo.2005.05.005.
    1. Hall WL, Vafeiadou K, Hallund J, Bugel S, Koebnick C, Reimann M, Ferrari M, Branca F, Talbot D, Dadd T, et al. Soy-isoflavone-enriched foods and inflammatory biomarkers of cardiovascular disease risk in postmenopausal women: interactions with genotype and equol production. Am J Clin Nutr. 2005;82:1260–1268.
    1. Fanti P, Asmis R, Stephenson TJ, Sawaya BP, Franke AA. Positive effect of dietary soy in ESRD patients with systemic inflammation – correlation between blood levels of the soy isoflavones and the acute-phase reactants. Nephrol Dial Transplant. 2006;21:2239–2246. doi: 10.1093/ndt/gfl169.
    1. Nasca MM, Zhou JR, Welty FK. Effect of soy nuts on adhesion molecules and markers of inflammation in hypertensive and normotensive postmenopausal women. Am J Cardiol. 2008;102:84–86. doi: 10.1016/j.amjcard.2008.02.100.
    1. Campbell CG, Brown BD, Dufner D, Thorland WG. Effects of soy or milk protein during a high-fat feeding challenge on oxidative stress, inflammation, and lipids in healthy men. Lipids. 2006;41:257–265. doi: 10.1007/s11745-006-5095-5.
    1. Charles C, Yuskavage J, Carlson O, John M, Tagalicud AS, Maggio M, Muller DC, Egan J, Basaria S. Effects of high-dose isoflavones on metabolic and inflammatory markers in healthy postmenopausal women. Menopause. 2008
    1. Phipps WR, Wangen KE, Duncan AM, Merz-Demlow BE, Xu X, Kurzer MS. Lack of effect of isoflavonic phytoestrogen intake on leptin concentrations in premenopausal and postmenopausal women. Fertil Steril. 2001;75:1059–1064. doi: 10.1016/S0015-0282(01)01777-0.
    1. Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med. 1995;333:276–282. doi: 10.1056/NEJM199508033330502.
    1. Deurenberg P, Yap M, van Staveren WA. Body mass index and percent body fat: a meta analysis among different ethnic groups. Int J Obes Relat Metab Disord. 1998;22:1164–1171. doi: 10.1038/sj/ijo/0800741.
    1. Yin N, Wang D, Zhang H, Yi X, Sun X, Shi B, Wu H, Wu G, Wang X, Shang Y. Molecular mechanisms involved in the growth stimulation of breast cancer cells by leptin. Cancer Res. 2004;64:5870–5875. doi: 10.1158/0008-5472.CAN-04-0655.
    1. Register TC, Cann JA, Kaplan JR, Williams JK, Adams MR, Morgan TM, Anthony MS, Blair RM, Wagner JD, Clarkson TB. Effects of soy isoflavones and conjugated equine estrogens on inflammatory markers in atherosclerotic, ovariectomized monkeys. J Clin Endocrinol Metab. 2005;90:1734–1740. doi: 10.1210/jc.2004-0939.
    1. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem. 1987;262:5592–5595.
    1. Kelley DS. Modulation of human immune and inflammatory responses by dietary fatty acids. Nutrition. 2001;17:669–673. doi: 10.1016/S0899-9007(01)00576-7.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj